D. E. Edmondson, C. Binda, J. Wang, A. K. Upadhyay, and A. Mattevi, Molecular and Mechanistic Properties of the Membrane-Bound Mitochondrial Monoamine Oxidases, Biochemistry, vol.48, pp.4220-4230, 2009.

R. R. Rona, Monoamine Oxidases: The Biochemistry of the Proteins As Targets in Medicinal Chemistry and Drug Discovery, Curr. Top. Med. Chem, vol.12, pp.2189-2209, 2012.

H. A. Blair, S. Dhillon, and . Safinamide, A Review in Parkinson's Disease, CNS Drugs, vol.31, pp.169-176, 2017.

R. De-la-fuente-fernández, V. Sossi, Z. Huang, S. Furtado, J. Lu et al.,

D. B. Ruth, T. J. Stoessl, and A. J. , Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias, Brain, vol.127, pp.2747-2754, 2004.

D. Maggiorani, N. Manzella, D. E. Edmondson, A. Mattevi, A. Parini et al., Monoamine Oxidases, Oxidative Stress, and Altered Mitochondrial Dynamics in Cardiac Ageing, Oxid. Med. Cell. Longev, p.3017947, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02446034

J. B. Wu, L. Yin, C. Shi, Q. Li, P. Duan et al.,

M. Lewis, Y. Wang, T. Lin, C. Pan, E. M. Posadas et al.,

K. Maoa-, Dependent Activation of Shh-IL6-RANKL Signaling Network Promotes, p.27

, Prostate Cancer Metastasis by Engaging Tumor-Stromal Cell Interactions. Cancer Cell, vol.31, pp.368-382, 2017.

M. P. Czech, Macrophages dispose of catecholamines in adipose tissue

A. Gaspar, M. J. Matos, J. Garrido, E. Uriarte, and F. Borges, Chromone: A Valid Scaffold in Medicinal Chemistry, Chem. Rev, vol.114, pp.4960-4992, 2014.

J. Reis, A. Gaspar, N. Milhazes, and F. Borges, Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances, J. Med. Chem, vol.60, pp.7941-7957, 2017.

A. Gaspar, J. Reis, A. Fonseca, N. Milhazes, D. Viña et al.,

, Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors

, Med. Chem. Lett, vol.21, pp.707-709, 2011.

A. Gaspar, T. Silva, M. Yáñez, D. Vina, F. Orallo et al.,

, Monoamine Oxidase Inhibitors. J. Med. Chem, vol.54, pp.5165-5173, 2011.

F. Cagide, T. Silva, J. Reis, A. Gaspar, F. Borges et al., Discovery of two new classes of potent monoamine oxidase-B inhibitors by tricky chemistry, Chem. Comm, vol.51, pp.2832-2835, 2015.

J. Reis, F. Cagide, D. Chavarria, T. Silva, C. Fernandes et al., Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors, J. Med. Chem, vol.59, pp.5879-5893, 2016.

F. Giulio, V. Santiago, J. M. Maria, U. Eugenio, C. Enzo et al.,

, Oxidase Inhibitors: Ten Years of Docking Studies, Curr. Top. Med. Chem, vol.12, pp.2145-2162, 2012.

C. Binda, J. Wang, L. Pisani, C. Caccia, A. Carotti et al.,

D. E. Mattevi and A. , Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs, J. Med. Chem, vol.50, pp.5848-5852, 2007.

K. Mazmanian, K. Sargsyan, C. Grauffel, T. Dudev, and C. Lim, Preferred Hydrogen-Bonding Partners of Cysteine: Implications for Regulating Cys Functions, J. Phys. Chem. B, vol.120, pp.10288-10296, 2016.

N. Echols, N. W. Moriarty, H. E. Klei, P. V. Afonine, G. Bunkóczi et al.,

J. Mccoy, A. J. Oeffner, R. D. Read, R. J. Terwilliger, T. C. Adams et al., Automating crystallographic structure solution and refinement of protein-ligand complexes, Acta Crystallogr. D, vol.70, pp.144-154, 2014.

M. Li, C. Binda, A. Mattevi, and D. E. Edmondson, Functional Role of the "Aromatic Cage" in Human Monoamine Oxidase B: Structures and Catalytic Properties of Tyr435 Mutant Proteins, Biochemistry, vol.45, pp.4775-4784, 2006.

C. Binda, F. Hubálek, M. Li, Y. Herzig, J. Sterling et al., Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the N-Propargylaminoindan, Class. J. Med. Chem, vol.47, pp.1767-1774, 2004.

M. Zhou and N. Panchuk-voloshina, A One-Step Fluorometric Method for the

, Continuous Measurement of Monoamine Oxidase Activity. Anal. Biochem, vol.253, pp.169-174, 1997.

R. A. Copeland, Tight Binding Inhibitors, Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis, pp.304-317, 2000.

S. Cha, R. P. Agarwal, and R. E. Parks, Tight-binding inhibitors-II: Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and 29 of human erythrocytic adenosine deaminase by coformycin, Biochem. Pharmacol, vol.24, pp.2187-2197, 1975.

M. Li, F. E. Hubálek, P. Newton-vinson, and D. E. Edmondson, High-Level Expression of Human Liver Monoamine Oxidase A in Pichia pastoris: Comparison with the Enzyme Expressed in Saccharomyces cerevisiae, Protein Expr. Purif, vol.24, pp.152-162, 2002.

P. Newton-vinson, F. Hubalek, and D. E. Edmondson,

, Human Liver Monoamine Oxidase B in Pichia pastoris, Protein Expr. Purif, vol.20, pp.334-345, 2000.

P. J. Henderson, A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors, Acta Crystallogr. D, vol.127, pp.125-132, 1972.

, Collaborative Computational Project, N. The CCP4 Suite: Programs for protein Crystallography, Acta Crystallogr, vol.50, pp.760-767, 1994.

P. Emsley, B. Lohkamp, W. G. Scott, and K. Cowtan, Features and development of Coot, Acta Crystallogr. D, pp.486-501, 2010.

G. N. Murshudov, P. Skubak, A. A. Lebedev, N. S. Pannu, R. A. Steiner et al., Vagin, A. A. REFMAC5 for the refinement of macromolecular crystal structures, Acta Crystallogr, pp.67-355, 2011.

S. Mcnicholas, E. Potterton, K. S. Wilson, and M. E. Noble, Presenting your structures: the CCP4mg molecular-graphics software, Acta Crystallogr. D, vol.67, pp.386-394, 2011.